MAPK3 and breast cancer: As ORAI1 [11] and TRPC1 [25] regulate ERK1/2 activity in other cell types we assessed constitutive ERK1/2 phosphorylation in MDA-MB-468 breast cancer cells with ORAI1 or TRPC1 silencing.